FDA gives clearance to Advanced Cell Technology, for their First Clinical Trial
US Food and Drug Administration (FDA) has cleared the Advanced Cell Technology, Inc.’s Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells…
Recent Comments